Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603363's Days Payable is ranked better than 66.37% of 1891
companies
in the Consumer Packaged Goods industry
Industry Median: 44.15
vs SHSE:603363: 61.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Aonong Biological Technology Grouporp Days Payable Chart
Fujian Aonong Biological Technology Grouporp Annual Data
SHSE:603363 vs ADM, BG, TSN: Days Payable Comparison
For the Farm Products subindustry, Fujian Aonong Biological Technology Grouporp's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fujian Aonong Biological Technology Grouporp Days Payable vs Consumer Packaged Goods Industry
Fujian Aonong Biological Technology Grouporp Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Aonong Biological Technology Grouporp (SHSE:603363) has a Days Payable of 64.80 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors. This is near median its historical median of 67.63. Over the past decade, Fujian Aonong Biological Technology Grouporp's Days Payable has ranged from 43.11 to 114.10. According to the industry distribution chart, Fujian Aonong Biological Technology Grouporp ranks #636 out of 1891 companies in the Consumer Packaged Goods industry, placing it in the top 33.6%.
Is Fujian Aonong Biological Technology Grouporp's Days Payable too high?
Fujian Aonong Biological Technology Grouporp's current Days Payable of 64.80 is near median its 10-year median of 67.63. Over the past 10 years, this metric has ranged from a low of 43.11 to a high of 114.10. The Consumer Packaged Goods industry median Days Payable is 44.15. Fujian Aonong Biological Technology Grouporp's value of 64.80 is 46.8% above this industry median. Based on the distribution chart, Fujian Aonong Biological Technology Grouporp ranks #636 out of 1891 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Fujian Aonong Biological Technology Grouporp has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fujian Aonong Biological Technology Grouporp's Days Payable compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Fujian Aonong Biological Technology Grouporp ranks #636 out of 1891 companies for Days Payable. This puts Fujian Aonong Biological Technology Grouporp in the upper half of its industry. The industry median Days Payable is 44.15. Fujian Aonong Biological Technology Grouporp's value of 64.80 is 46.8% above this benchmark. Historically, Fujian Aonong Biological Technology Grouporp's own Days Payable has ranged from 43.11 to 114.10 over the past decade. While the company's 10-year median is 67.63 vs. the industry median of 44.15, Fujian Aonong Biological Technology Grouporp has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,891 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fujian Aonong Biological Technology Grouporp's current Days Payable of 64.80 is 46.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fujian Aonong Biological Technology Grouporp's current Days Payable is 64.80, which is near median its own 10-year median of 67.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Aonong Biological Technology Grouporp stock overvalued right now?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp (SHSE:603363) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.32, compared to a current price of ¥2.67 — trading 102.3% above its estimated fair value. The current Days Payable is 64.80, which is near median its 10-year median of 67.63 and 46.8% above the Consumer Packaged Goods industry median of 44.15. Fujian Aonong Biological Technology Grouporp's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fujian Aonong Biological Technology Grouporp (SHSE:603363), the current Days Payable is 64.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fujian Aonong Biological Technology Grouporp (SHSE:603363) Overvalued in 2026?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp stock appears to be overvalued.
The current stock price of ¥2.67 is trading 102.3% above its estimated GF Value™ of ¥1.32.
GuruFocus considers Fujian Aonong Biological Technology Grouporp to be Significantly Overvalued.
Key valuation signals for SHSE:603363:
Days Payable: 64.80 (near median its 10-year median of 67.63)
GF Value™: ¥1.32 vs. price of ¥2.67 (102.3% above fair value)
Industry Position: 46.8% above the Consumer Packaged Goods median (#636 of 1891)
No single metric tells the full story. See the SHSE:603363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fujian Aonong Biological Technology Grouporp Business Description
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
31GF Score
Get the complete analysis for SHSE:603363
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603363 has been successfully added to your 
